<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05797402</url>
  </required_header>
  <id_info>
    <org_study_id>2020YFC2004800</org_study_id>
    <nct_id>NCT05797402</nct_id>
  </id_info>
  <brief_title>Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases</brief_title>
  <official_title>Construction of Integrated Management and Sharing Platform for Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Geriatric Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan TongJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to establish a clinical database and biobank for elderly patients with&#xD;
      multiple diseases. The collected data will include demographic information, comorbidity&#xD;
      characteristic, FRAIL scale, age-adjusted Charlson comorbidity index, relevant blood tests,&#xD;
      the results of imaging examination, prescription of drugs, length of hospital stay, number of&#xD;
      overall rehospitalizations and death. With this database, the investigators intend to&#xD;
      formulate an individualized treatment strategy for these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to the China Health and Aging Tracking Survey, a significant proportion of elderly&#xD;
      individuals aged over 65 suffer from two or more chronic diseases, with prevalence rates&#xD;
      ranging from 22.5% to 47.5%. However, due to the decentralized storage of health data, lack&#xD;
      of standardization, and collaboration barriers, it is challenging to make use of this&#xD;
      information in a meaningful way.Therefore, there is an urgent need to overcome the technical&#xD;
      challenges and build an intelligent diagnosis and treatment system for this vulnerable&#xD;
      population.&#xD;
&#xD;
      To achieve this goal, it is necessary to establish a clinical database and biobank that&#xD;
      includes data on all elderly patients with multimorbidity. This will enable researchers to&#xD;
      conduct clinical research on various factors, including clinical and biological predictors of&#xD;
      adverse events such as emergency visits, strokes, heart failure, myocardial infarction,&#xD;
      tumors, and acute chronic obstructive pulmonary disease. Additionally, the database will&#xD;
      facilitate the development of systematic and individualized evaluation tools for elderly&#xD;
      patients with multimorbidity, identify prognostic factors that improve short- and long-term&#xD;
      outcomes, and enable the participation in multi-center trials at the national or&#xD;
      international level. Ultimately, this effort will help establish clinical database and&#xD;
      biobank data collection standards for future studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of geriatric syndromes including falls, cognitive impairment, dizziness and frailty</measure>
    <time_frame>1 year</time_frame>
    <description>collection of clinical data in the medical record and follow-up update</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of survival rate</measure>
    <time_frame>1 year</time_frame>
    <description>collection of clinical data in the medical record and follow-up update</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">10000000</enrollment>
  <condition>Comorbidities and Coexisting Conditions</condition>
  <condition>Old Age; Debility</condition>
  <arm_group>
    <arm_group_label>young-aged patients</arm_group_label>
    <description>Patients aged 18 to 45 years old.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>middle-aged patients</arm_group_label>
    <description>Patients aged 46 to 64 years old.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>elderly patients</arm_group_label>
    <description>Patients aged 65 and older.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        hospital based group&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (1) written and informed consent, (2) participants aged 18 years or older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) Unwilling to participate in the study, (2) Unable or unwilling to cooperate with&#xD;
             the baseline or follow-up data collection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Shao-ping Nie, MD,PhD</last_name>
    <phone>8613701186772</phone>
    <email>spnie@ccmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shao-Ping Nie, MD, PhD</last_name>
      <phone>86-10-84005256</phone>
      <email>spnie@ccmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Shao-Ping Nie, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>February 22, 2023</study_first_submitted>
  <study_first_submitted_qc>April 2, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>April 2, 2023</last_update_submitted>
  <last_update_submitted_qc>April 2, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Shao-Ping Nie</investigator_full_name>
    <investigator_title>Professor of Medicine,Director,Department of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Cognition Disorders</keyword>
  <keyword>Frailty</keyword>
  <keyword>Coronary heart disease</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Valvular heart disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

